Celon Pharma SA (CLN) — Net Asset Momentum
Celon Pharma SA (CLN) recorded a net asset momentum of -18.4% as of December 2025, with net assets of zł363.25 Million PLN. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See Celon Pharma SA (CLN) defensive interval to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
Celon Pharma SA Net Asset Momentum (2012–2025)
This chart tracks Celon Pharma SA's year-over-year net asset growth across 14 annual reporting periods from 2012 to 2025. The most recent momentum reading is -18.4%, with net assets of zł363.25 Million PLN as of December 2025. Read debt load of Celon Pharma SA for a breakdown of total debt and financial obligations.
Annual Net Asset History for Celon Pharma SA (2012–2025)
The table below shows the complete annual net asset history for Celon Pharma SA from 2012 to 2025, covering 14 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see how much is Celon Pharma SA worth.
| Year | Net Assets (PLN) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | zł363.25 Million | zł457.46 Million | zł94.21 Million | ▼ -18.4% |
| 2024 | zł445.21 Million | zł543.79 Million | zł98.59 Million | ▼ -0.1% |
| 2023 | zł445.56 Million | zł569.31 Million | zł123.75 Million | ▼ -7.1% |
| 2022 | zł479.65 Million | zł608.93 Million | zł129.29 Million | ▼ -13.4% |
| 2021 | zł554.00 Million | zł707.14 Million | zł153.14 Million | ▲ +27.5% |
| 2020 | zł434.67 Million | zł703.64 Million | zł268.97 Million | ▼ -2.3% |
| 2019 | zł445.04 Million | zł591.35 Million | zł146.31 Million | ▼ -0.8% |
| 2018 | zł448.73 Million | zł563.67 Million | zł114.94 Million | ▲ +2.0% |
| 2017 | zł439.85 Million | zł525.05 Million | zł85.20 Million | ▲ +9.3% |
| 2016 | zł402.50 Million | zł464.32 Million | zł61.82 Million | ▲ +299.2% |
| 2015 | zł100.82 Million | zł168.29 Million | zł67.47 Million | ▲ +44.8% |
| 2014 | zł69.62 Million | zł105.44 Million | zł35.82 Million | ▲ +33.4% |
| 2013 | zł52.20 Million | zł82.59 Million | zł30.39 Million | ▼ -6.1% |
| 2012 | zł55.57 Million | zł69.80 Million | zł14.22 Million | — |